158 related articles for article (PubMed ID: 2804473)
1. Antitumor effects of rhodium (II) citrate in mice bearing Ehrlich tumors.
Zyngier S; Kimura E; Najjar R
Braz J Med Biol Res; 1989; 22(3):397-401. PubMed ID: 2804473
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of rhodium (II) complexes on mice bearing Ehrlich tumors.
Reibscheid EM; Zyngier S; Maria DA; Mistrone RJ; Sinisterra RD; Couto LG; Najjar R
Braz J Med Biol Res; 1994 Jan; 27(1):91-4. PubMed ID: 8173534
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of rhodium(II) acetate in tumor-bearing mice.
Erck A; Sherwood E; Bear JL; Kimball AP
Cancer Res; 1976 Jul; 36(7 PT 1):2404-9. PubMed ID: 1277146
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation in the thymus of Ehrlich ascites tumor bearing mice.
Suciu D; Uray Z
Neoplasma; 1979; 26(3):275-80. PubMed ID: 530335
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobicity of several rhodium(II) carboxylates correlated with their biologic activity.
Howard RA; Sherwood E; Erck A; Kimball AP; Bear JL
J Med Chem; 1977 Jul; 20(7):943-6. PubMed ID: 874969
[TBL] [Abstract][Full Text] [Related]
6. The reversal of effects of methotrexate on toxicity and glucose transport reduction by thymidine in Ehrlich ascites tumor bearing mice.
Fung KP; Ng SW; Choy YM
Cancer Biochem Biophys; 1986 Oct; 8(4):249-56. PubMed ID: 3802046
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles on mice bearing breast cancer: a systemic toxicity assay.
Peixoto RC; Miranda-Vilela AL; de Souza Filho J; Carneiro ML; Oliveira RG; da Silva MO; de Souza AR; Báo SN
Tumour Biol; 2015 May; 36(5):3325-36. PubMed ID: 25528215
[TBL] [Abstract][Full Text] [Related]
8. Effect of altered lighting regimens, time-limited feeding, and presence of Ehrlich ascites carcinoma on the circadian rhythm in DNA synthesis of mouse spleen.
Burns ER; Scheving LE; Pauly JE; Tsai T
Cancer Res; 1976 May; 36(5):1538-44. PubMed ID: 1268817
[TBL] [Abstract][Full Text] [Related]
9. Studies of rhodium(II) carboxylates as potential antitumor agents.
Erck A; Rainen L; Whileyman J; Chang IM; Kimball AP; Bear J
Proc Soc Exp Biol Med; 1974 Apr; 145(4):1278-83. PubMed ID: 4827739
[No Abstract] [Full Text] [Related]
10. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
Myers CE; Young RC; Chabner BA
Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Rhodium(II) carboxylates with molecules of biologic importance.
Bear JL; Gray HB; Rainen L; Chang IM; Howard R; Serio G; Kimball AP
Cancer Chemother Rep; 1975; 59(3):611-20. PubMed ID: 1106839
[TBL] [Abstract][Full Text] [Related]
12. Study of Antitumor Activity of Sodium Phenylbutyrate, Histon Deacetylase Inhibitor, on Ehrlich Carcinoma Model.
Fadeev NP; Kharisov RI; Kovan'ko EG; Pustovalov YI
Bull Exp Biol Med; 2015 Sep; 159(5):652-4. PubMed ID: 26468021
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclophosphamide on circadian rhythms in mitosis and DNA synthesis in normal mice and mice bearing the Ehrlich ascites carcinoma.
Morgans LF; Burns ER
Oncology; 1984; 41(2):135-9. PubMed ID: 6709276
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor inhibits thymidine incorporation in Ehrlich ascites tumor cells in vivo.
Lombardero J; Pérez R; Lage A
Neoplasma; 1986; 33(4):423-9. PubMed ID: 3489898
[TBL] [Abstract][Full Text] [Related]
15. Effects of pH and citrate concentrations on in vitro binding of 67Ga to Ehrlich ascites tumor cells.
Suzuki T; Okada Y; Kohno H; Ohkubo Y; Kubodera A
Int J Nucl Med Biol; 1985; 12(1):73-4. PubMed ID: 3859477
[No Abstract] [Full Text] [Related]
16. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Holm B; Jensen PB; Sehested M
Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect and toxicity of free rhodium (II) citrate and rhodium (II) citrate-loaded maghemite nanoparticles in mice bearing breast cancer.
Carneiro ML; Peixoto RC; Joanitti GA; Oliveira RG; Telles LA; Miranda-Vilela AL; Bocca AL; Vianna LM; da Silva IC; de Souza AR; Lacava ZG; Báo SN
J Nanobiotechnology; 2013 Feb; 11():4. PubMed ID: 23414068
[TBL] [Abstract][Full Text] [Related]
18. Circadian rhythm in DNA synthesis in mouse thymus: effect of altered lighting regimens, restricted feeding and presence of Ehrlich ascites tumor.
Pauly JE; Scheving LE; Burns ER; Tsai TH
Anat Rec; 1976 Mar; 184(3):275-84. PubMed ID: 1259179
[TBL] [Abstract][Full Text] [Related]
19. Antitumor action of rhodium (I) and iridium (I) complexes.
Giraldi T; Sava G; Mestroni G; Zassinovich G; Stolfa D
Chem Biol Interact; 1978 Sep; 22(2-3):231-8. PubMed ID: 699174
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the incorporation of 3H-labeled thymidine in Ehrlich ascites cells in vivo and in vitro].
Steenbeck L; Schmaglowski S
Arch Geschwulstforsch; 1967; 29(2):163-6. PubMed ID: 5585722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
